Cyclobenzaprine and Trospium / Xanomeline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Cyclobenzaprine
Trospium / Xanomeline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Cyclobenzaprine (a muscle relaxant) has an atropine-like effect, meaning it can cause drying and slowing effects in the body. Cobenfy contains trospium, which works in a similar drying way. When you take both, these effects can add up.
You might notice things like dry mouth, blurry vision, constipation, trouble urinating, dizziness, or a fast heartbeat. This concern is based more on how these drugs work than on real-world reports, so it may never cause you a problem. Still, it is worth mentioning to your pharmacist or doctor. They can watch for these effects and adjust your plan if needed. Please do not stop either medicine on your own.
Effect: Additive anticholinergic (atropine-like) burden when cyclobenzaprine is combined with trospium (Cobenfy).
- Mechanism: Pharmacodynamic. Cyclobenzaprine has intrinsic atropine-like activity; trospium is an antimuscarinic. Neither is a prodrug here, so effects are additive rather than metabolic. Exact mechanism unspecified.
- Direction: Increased anticholinergic effects.
- Evidence: Theoretical; severity rated major. Onset unspecified.
- Monitoring: Watch for dry mouth, urinary retention, constipation, blurred vision, tachycardia, confusion (especially in elderly). Individualize dosing and monitor more closely.
What happens
An increased risk of atropine-like adverse reactions
Interaction Deep Dive
Because cyclobenzaprine possesses atropine-like activity, care should be taken when it is given together with anticholinergics1.
Why it happens (mechanism)
Unknown
How to manage this interaction
Your care team can manage this combination safely. The main step is watching for added anticholinergic effects and tailoring your treatment.
- Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise.
- Your team may monitor you more closely and, if needed, the dose may be adjusted and individualized.
- Tell your pharmacist or doctor if you notice dry mouth, constipation, trouble urinating, blurred vision, confusion, or a racing heartbeat.
- Report these promptly, especially if you are older, since these effects can be stronger.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Cyclobenzaprine and Trospium / Xanomeline together?
Taking cyclobenzaprine with Cobenfy (trospium) can add up their drying, atropine-like side effects, so watch for things like dry mouth, constipation, or trouble urinating and let your care team know. This is a theoretical concern, and your team can manage it with monitoring and dose adjustments if needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Cyclobenzaprine and Trospium / Xanomeline interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Cyclobenzaprine and Trospium / Xanomeline interaction managed?
Your care team can manage this combination safely. The main step is watching for added anticholinergic effects and tailoring your treatment. Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Your team may monitor you more closely and, if needed, the dose may be adjusted and individualized. Tell your pharmacist or doctor if you notice dry mouth, constipati… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Cyclobenzaprine or Trospium / Xanomeline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: TONMYA(TM) sublingual tablets, cyclobenzaprine HCl sublingual tablets. Tonix Pharmaceuticals, Inc (per manufacturer), Chatham, NJ, 2025. DailyMed
Keep reading about Cyclobenzaprine
Keep reading about Trospium / Xanomeline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist